Madison Vaccines Incorporated   Report issue

For profit Phase 2
Founded: Madison WI United States (2012)

Organization Overview

First Clinical Trial
2015
NCT02411786
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Madison Vaccines, Inc | Madison Vaccines Inc. (MVI)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 6